STAAR Surgical Company (STAA) Financial Statements (2024 and earlier)
Company Profile
Business Address |
1911 WALKER AVE MONROVIA, CA 91016 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3851 - Ophthalmic Goods (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q1 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 220,726 | 188,113 | 192,007 | 203,847 | 211,639 | 211,333 | |||
Cash and cash equivalents | 183,038 | 127,432 | 94,695 | 89,968 | 86,480 | 129,242 | |||
Short-term investments | 37,688 | 60,681 | 97,312 | 113,879 | 125,159 | 82,091 | |||
Receivables | 97,160 | 114,556 | 98,322 | 68,171 | 65,113 | 56,984 | |||
Inventory, net of allowances, customer advances and progress billings | 35,130 | 31,061 | 25,482 | 27,808 | 24,161 | 19,930 | |||
Inventory | 35,130 | 31,061 | 25,482 | 27,808 | 24,161 | 19,930 | |||
Prepaid expense | 6,216 | 5,830 | 4,968 | 5,245 | 3,986 | 3,716 | |||
Other current assets | 762 | 932 | 668 | 536 | 811 | 424 | |||
Other undisclosed current assets | 5,275 | 6,576 | 6,556 | 7,264 | 6,013 | 4,523 | |||
Total current assets: | 365,269 | 347,068 | 328,003 | 312,871 | 311,723 | 296,910 | |||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 183 | 220 | 257 | 303 | 342 | 380 | |||
Operating lease, right-of-use asset | 34,387 | 34,992 | 31,530 | 31,182 | 30,270 | 29,503 | |||
Property, plant and equipment | 66,835 | 62,886 | 55,924 | 53,453 | 50,921 | 48,048 | |||
Long-term investments and receivables | 11,703 | 13,627 | 17,525 | 13,445 | 13,902 | 13,360 | |||
Long-term investments | 11,703 | 13,627 | 17,525 | 13,445 | 13,902 | 13,360 | |||
Intangible assets, net (including goodwill) | 1,786 | 1,786 | 1,786 | 1,951 | 1,959 | 1,957 | |||
Goodwill | 1,786 | 1,786 | 1,786 | 1,786 | 1,786 | 1,786 | |||
Intangible assets, net (excluding goodwill) | 165 | 173 | 171 | ||||||
Deferred income tax assets | 5,190 | 8,560 | 4,672 | 4,744 | 4,824 | 3,710 | |||
Other noncurrent assets | 3,339 | 2,382 | 954 | 956 | 957 | 808 | |||
Total noncurrent assets: | 123,423 | 124,453 | 112,648 | 106,034 | 103,175 | 97,766 | |||
TOTAL ASSETS: | 488,692 | 471,521 | 440,651 | 418,905 | 414,898 | 394,676 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 13,557 | 8,786 | 11,441 | 9,102 | 11,576 | 7,567 | |||
Accounts payable | 13,557 | 8,786 | 11,441 | 9,102 | 11,576 | 7,567 | |||
Debt | 165 | 164 | 162 | 171 | 169 | 167 | |||
Other liabilities | 40,938 | 36,265 | 31,925 | 28,949 | 30,741 | 29,072 | |||
Other undisclosed current liabilities | 10,376 | 11,560 | 10,666 | 8,841 | 9,230 | 8,514 | |||
Total current liabilities: | 65,036 | 56,775 | 54,194 | 47,063 | 51,716 | 45,320 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 42 | 84 | 125 | 167 | 210 | 26,284 | |||
Finance lease, liability | 42 | 84 | 125 | 167 | 210 | 252 | |||
Liabilities, other than long-term debt | 37,660 | 36,067 | 32,635 | 32,751 | 30,780 | 2,940 | |||
Asset retirement obligations | 103 | 98 | 101 | 218 | 220 | 158 | |||
Deferred income tax liabilities | 1,077 | 1,295 | 1,295 | 1,369 | 1,489 | 1,554 | |||
Liability, pension and other postretirement and postemployment benefits | 5,055 | 3,031 | 3,050 | 3,134 | 1,935 | 1,228 | |||
Operating lease, liability | 31,425 | 31,643 | 28,189 | 28,030 | 27,136 | 26,032 | |||
Total noncurrent liabilities: | 37,702 | 36,151 | 32,760 | 32,918 | 30,990 | 29,224 | |||
Total liabilities: | 102,738 | 92,926 | 86,954 | 79,981 | 82,706 | 74,544 | |||
Equity | |||||||||
Equity, attributable to parent | 385,954 | 378,595 | 353,697 | 338,924 | 332,192 | 320,132 | |||
Common stock | 488 | 488 | 485 | 483 | 482 | 482 | |||
Additional paid in capital | 436,947 | 436,117 | 419,594 | 409,303 | 404,189 | 398,448 | |||
Accumulated other comprehensive income (loss) | (4,113) | (2,886) | (2,521) | (937) | 156 | (310) | |||
Accumulated deficit | (47,368) | (55,124) | (63,861) | (69,925) | (72,635) | (78,488) | |||
Total equity: | 385,954 | 378,595 | 353,697 | 338,924 | 332,192 | 320,132 | |||
TOTAL LIABILITIES AND EQUITY: | 488,692 | 471,521 | 440,651 | 418,905 | 414,898 | 394,676 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q1 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 76,273 | 80,308 | 92,306 | 73,528 | 64,044 | 76,046 | ||
Cost of revenue (Cost of Goods and Services Sold) | (15,548) | (16,670) | (21,580) | (15,966) | (14,259) | (15,584) | ||
Gross profit: | 60,725 | 63,638 | 70,726 | 57,562 | 49,785 | 60,462 | ||
Operating expenses | (50,320) | (57,343) | (62,129) | (54,762) | (48,821) | (46,757) | ||
Operating income (loss): | 10,405 | 6,295 | 8,597 | 2,800 | 964 | 13,705 | ||
Nonoperating income (expense) | 3,334 | 451 | (105) | 1,919 | 5,015 | (1,128) | ||
Investment income, nonoperating | 74 | 277 | 77 | |||||
Gain (loss), foreign currency transaction, before tax | 1,331 | (1,384) | (1,890) | 34 | 3,197 | (2,129) | ||
Other nonoperating income | 304 | 71 | 10 | 63 | 27 | 27 | ||
Interest and debt expense | (2) | (3) | (3) | (4) | (4) | (5) | ||
Income (loss) from continuing operations before equity method investments, income taxes: | 13,737 | 6,743 | 8,489 | 4,715 | 5,975 | 12,572 | ||
Other undisclosed income from continuing operations before income taxes | 2 | 3 | 3 | 4 | 4 | 5 | ||
Income (loss) from continuing operations before income taxes: | 13,739 | 6,746 | 8,492 | 4,719 | 5,979 | 12,577 | ||
Income tax expense | (5,983) | (1,929) | (2,428) | (2,009) | (126) | (2,315) | ||
Income (loss) from continuing operations: | 7,756 | 4,817 | 6,064 | 2,710 | 5,853 | 10,262 | ||
Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 10,262 | |
Net income (loss) available to common stockholders, diluted: | 7,756 | 4,817 | 6,064 | 2,710 | 5,853 | 10,262 |
Comprehensive Income ($ in thousands)Annual | Quarterly
3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q1 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 7,756 | 4,817 | 6,064 | 2,710 | 5,853 | 10,262 | ||
Other comprehensive income (loss) | (1,227) | (365) | (1,584) | (1,093) | 466 | (559) | ||
Comprehensive income (loss), net of tax, attributable to parent: | 6,529 | 4,452 | 4,480 | 1,617 | 6,319 | 9,703 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.